Novavax Expects COVID Vaccine Targeting Omicron in Fourth Quarter

Novavax Inc said it expects to provide a COVID-19 vaccine targeting Omicron in the fourth quarter as it accelerates development of shots to protect against the BA.4 and BA.5 subvariants.
Reuters Health Information

source https://www.medscape.com/viewarticle/976700?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?